Skip to main content
. 2017 Jul 18;102(9):3226–3233. doi: 10.1210/jc.2017-00468

Table 3.

Provider- and Site-Level Predictors of Appropriate Testing in New Testosterone Patients (n = 99,045)

Variable Number of Patients (%) Fully Adjusted Modelsa Adjusted for Clustering by Provider and Site Odds Ratio (95% CI)
At Least 1 Low T (n = 78,525) At Least 2 Low T (n = 18,375) At Least 2 Low T in Morning (n = 5,379)
Provider age, y
 22–30 1,553 (1.6) 0.93 (0.79–1.09) 1.46b (1.23–1.73) 1.29 (0.98–1.68)
 31–40 15,194 (15.3) 0.98 (0.90–1.06) 1.23b (1.12–1.36) 1.30b (1.12–1.50)
 41–50 29,399 (29.7) 0.99 (0.92–1.07) 1.12b (1.03–1.22) 1.14 (1.00–1.30)
 51–60 38,206 (38.6) 1.03 (0.96–1.10) 1.11b (1.03–1.20) 1.12 (1.00–1.26)
 61+ 14,693 (14.8) ref. ref. ref.
Years in VA
 0, 1 16,150 (16.3) 0.96 (0.89–1.04) 0.79b (0.73–0.86) 0.82b (0.72–0.94)
 2–5 27,090 (27.4) 0.99 (0.92–1.06) 0.85b (0.79–0.92) 0.95 (0.85–1.07)
 6–10 25,127 (25.4) 1.03 (0.96–1.10) 0.86b (0.79–0.92) 0.91 (0.81–1.03)
 11–15 13,295 (13.4) 0.96 (0.89–1.04) 0.91 (0.84–0.99) 1.06 (0.93–1.20)
 16 or more 17,383 (17.6) ref. ref. ref.
Male sex
 Yes 53,590 (54.1) 0.88b (0.84–0.93) 0.87b (0.82–0.93) 0.88b (0.81–0.96)
Provider type
 MD, primary care 70,351 (71.0) ref. ref. ref.
 MD, endocrinology 912 (0.9) 1.29 (1.01–1.65) 2.09b (1.63–2.67) 2.14b (1.54–2.97)
 MD, urology 205 (0.2) 0.98 (0.65–1.47) 1.37 (0.88–2.14) 0.79 (0.36–1.73)
 MD, other specialty 7,300 (7.4) 1.32b (1.21–1.43) 1.32b (1.21–1.44) 1.12 (0.98–1.27)
 PA, primary care 4,016 (4.1) 0.83b (0.73–0.93) 0.87 (0.75–1.00) 1.01 (0.82–1.23)
 PA, non–primary care 1,411 (1.4) 1.20 (0.99–1.45) 1.19 (0.97–1.46) 1.30 (0.97–1.73)
 Nurse practitioner 14,526 (14.7) 0.92 (0.85–0.98) 0.97 (0.89–1.05) 1.02 (0.90–1.15)
 Pharmacist 243 (0.2) 1.04 (0.72–1.49) 0.89 (0.60–1.31) 0.73 (0.38–1.42)
 Other credentials 81 (0.1) 0.72 (0.42–1.24) 0.87 (0.46–1.66) 0.60 (0.18–2.01)
Region
 Northeast (n = 24)c 9,414 (9.5) ref. ref. ref.
 Midwest (n = 27)c 19,588 (19.8) 1.36b (1.26–1.47) 0.90 (0.83–0.99) 0.88 (0.78–1.01)
 South (n = 46)c 44,303 (44.7) 1.28b (1.19–1.37) 0.86b (0.79–0.93) 0.80b (0.72–0.90)
 West (n = 32)c 25,740 (26.0) 1.38b (1.28–1.49) 0.97 (0.90–1.06) 0.85 (0.75–0.97)
Whether patient received any care in VA at outpatient clinic outside of hospital
 Yes 75,103 (75.8) 0.97b (0.93–1.02) 0.91b (0.87–0.96) 0.83b (0.77–0.90)
Complexity group
 Category 1a (most complex) 44,184 (44.6) 1.10b (1.03–1.17) 1.20b (1.12–1.29) 1.33b (1.18–1.49)
 Category 1b 12,007 (12.1) 0.95 (0.88–1.03) 1.07 (0.98–1.17) 1.00 (0.86–1.16)
 Category 1c 20,112 (20.3) 1.00 (0.93-1.08) 1.10 (1.02–1.20) 1.23b (1.08–1.41)
 Category 2 11,650 (11.8) 0.82b (0.76–0.89) 0.98 (0.89–1.07) 1.17 (1.01–1.35)
 Category 3 (least complex) 11,092 (11.2) ref. ref. ref.

Abbreviation: PA, physician assistant.

a

Each fully adjusted model uses all provider and site characteristics specified on the table.

b

Odds ratio differs from the reference group; that is, patients without the specified factor, at the level of P < 0.01. All other odds ratios do not differ from the reference group at the 0.01 level.

c

Total number of sites per region.